Biologics, Manufacturing Process Changes, and Biosimilars

The process for the evaluation of a biosimilar is fundamentally the same as the evaluation of manufacturing process changes for reference biologics. In this webinar, Dr. Andrew Zelenetz discusses this context for the comparability exercise for biosimilars.